Chapter 10: Appeals to Authority and False Expertise

Propaganda, Power, and Persuasion

Part Two: Techniques

Opening: The Doctor in the Advertisement

Ingrid Larsen clicked to the next slide and let it sit on the screen for a moment before she said anything.

The image was in black and white — a doctor in a white coat, stethoscope draped around his neck, holding a cigarette between two fingers with the studied casualness of a man accustomed to being photographed. The text beneath him read: "More Doctors Smoke Camels Than Any Other Cigarette." The year: 1946. The company: R.J. Reynolds Tobacco.

The seminar room at Hartwell University was quiet. Most of the students in Ingrid's graduate colloquium on European regulatory approaches to health misinformation had seen images like this before — in history classes, in documentary films, in satirical montages. They thought they knew what to make of it. The doctor in the advertisement was a relic, a curio from a less sophisticated time.

Then Ingrid clicked to the next slide.

This one was in full color, high-resolution, shot with the warm-toned aesthetic of contemporary wellness content. A young woman with clear skin and a confident smile — her Instagram bio listed an MD from a prestigious medical school — held up a supplement bottle. The post had 47,000 likes. The caption explained that she had been taking this particular formulation of adaptogens and collagen peptides for six months and that her patients, energy levels, and skin had all improved dramatically. A small tag at the bottom, easy to miss: #ad.

Ingrid let the two images sit side by side.

"Different century," she said. "Same technique."

She advanced to the next slide, which showed the architecture behind the second image: the influencer's agency, the supplement company's funding structure, the clinical evidence for the product — which did not exist — and the regulatory gap that permitted the post to run without challenge. A doctor's credentials, real ones, had been deployed not to inform but to transfer the authority earned in medical school onto a claim that medical school would never have taught her to make.

"The white coat," Ingrid said, "does not travel with the doctor. It travels with whoever is holding the camera."

She had been studying this for three years — the specific ways that authority signals migrate from genuine to manufactured contexts, how the brain's evolved deference to expertise gets reverse-engineered into a delivery mechanism for misinformation. The European regulatory framework she was analyzing tried to address this gap: mandatory disclosure for paid health claims, credential verification requirements for medical influencers, fines that matched advertising revenue. The American framework did not.

But regulations were downstream of the psychological mechanism. To understand why regulations were needed at all — and why they were so difficult to enforce — you had to understand why the white coat worked in the first place.

That was where the chapter began.

Why Authority Works: The Expertise Heuristic and Its Exploitation

The capacity to defer to expertise is not a flaw in human reasoning. It is one of its most valuable features.

No individual human being can verify, from first principles, more than a tiny fraction of the claims on which their daily life depends. The person who drives to work trusts engineers they have never met to have designed a safe vehicle, chemists they will never know to have refined fuel that will not explode, civil engineers to have built a road that will not collapse. The person who takes a prescribed medication trusts a physician, a pharmacologist, a clinical trial team, a regulatory body, and a pharmaceutical manufacturer — a chain of expertise that stretches back decades and across continents — to have established that the medication will help more than it will harm.

This reliance is not naivety. It is rational. In a world of irreducible complexity and specialization, deferring to those with verified expertise in their domains allows individuals to function without devoting their lives to independent verification of every factual claim. The alternative — demanding personal expertise before extending any trust — would make coordinated civilization impossible.

The psychologist Robert Cialdini, whose taxonomy of influence principles was introduced in Chapter 2, identified authority as one of his six core mechanisms of persuasion. The authority principle holds that people are inclined to comply with the directives and accept the claims of those they perceive as legitimate authorities — experts, officials, persons with visible markers of institutional standing. Cialdini documented compliance effects from superficial authority markers: wearing a uniform increased compliance in requests, using formal titles increased the perceived credibility of claims, citing institutional affiliations substantially elevated the persuasive weight of arguments.

These effects are not the result of deliberate, conscious reasoning. They operate through what Kahneman's dual-process framework (Chapter 2) describes as System 1 — fast, automatic, pattern-matching cognition that uses heuristics to reach conclusions without effortful analysis. The expertise heuristic runs something like: this person has markers of authority in this domain, therefore their claims in this domain are likely to be true. For most decisions, in most contexts, this heuristic serves us well. It is when the markers of authority are detached from the substance of genuine expertise that the heuristic becomes a vulnerability.

Stanley Milgram's obedience experiments, conducted at Yale University between 1961 and 1963, provided the most disturbing evidence of how far authority compliance could extend. Milgram told participants they were involved in a study of learning and memory. A confederate posing as a fellow participant was assigned the role of "learner" and strapped into a chair in an adjacent room. The real participant, designated "teacher," was instructed by an experimenter in a gray laboratory coat to administer electric shocks of increasing intensity each time the learner gave a wrong answer. The shocks were not real, but the participants did not know this. The shock generator had clearly labeled switches running from 15 volts (labeled "Slight Shock") to 450 volts (labeled "XXX," beyond "Danger: Severe Shock").

Milgram expected that participants would refuse well before reaching dangerous voltages. He asked colleagues and psychiatric professionals to predict the rate of compliance; most estimated that fewer than 1 percent would reach the maximum voltage. In the baseline condition, 65 percent did. The experimenter's authority — a scientist in an institutional setting, giving calmly insistent instructions — was sufficient to induce the majority of ordinary people to administer what they believed were potentially lethal shocks to a screaming stranger.

Milgram theorized that participants entered what he called the "agentic state" — a psychological mode in which individuals perceive themselves as instruments of a legitimate authority's will rather than as autonomous moral agents. Responsibility, in this state, felt as though it had been transferred upward to the authority figure. This mechanism is not unique to experimental settings. It describes a broad tendency in human social behavior: when legitimate authority directs, the individual's sense of personal moral agency is suppressed.

For propaganda purposes, the exploitation of this tendency does not require coercion. It requires only that authority signals be present — the lab coat, the institutional letterhead, the professional title, the credential cited in small print. When these signals are genuine, deference serves its proper function. When they are manufactured or borrowed from contexts where they were earned to contexts where they do not apply, they become instruments of manipulation.

The challenge is that distinguishing manufactured from genuine authority requires exactly the kind of effortful, analytical System 2 reasoning that authority signals are designed to bypass.

The anthropological and evolutionary backdrop to this challenge is worth briefly considering, because it helps explain why the authority heuristic is so robust and so difficult to consciously override. Human societies have depended on the transmission of specialized knowledge across generations for all of recorded history and deep into the prehistoric past. The elders who knew where water sources were located in drought years, the healers who understood which plants reduced fever, the navigators who could read weather and currents — these specialists held knowledge that their communities could not afford to discount. The cognitive systems that enabled rapid, low-cost deference to recognized domain experts were adaptive. They allowed communities to act effectively on knowledge they could not individually verify.

The challenge of the modern information environment is not that this adaptive mechanism has failed, but that the environment has changed faster than the mechanism can adapt to. The expert signals that were reliably correlated with domain knowledge in ancestral environments — institutional membership, recognized social standing, accumulated demonstrated competence — can now be manufactured, borrowed, and deployed at scale by actors whose relationship to genuine expertise is far weaker than the signals imply. The mechanism has not changed; the signal environment has.

There is a further dimension of the authority heuristic that is specifically relevant to the manufactured doubt context: the relationship between authority and uncertainty. When a question is simple and the evidence is clear, authority figures are not needed to resolve it — the evidence itself provides resolution. Authority is most influential precisely when questions are technically complex and the evidence is difficult for non-specialists to directly evaluate. This is the specific condition under which manufactured doubt campaigns operate. They select questions where the evidence requires specialized knowledge to interpret — the dose-response relationships in tobacco carcinogenesis, the attribution methodology in climate science, the immunological mechanisms of vaccine-induced immunity — and deploy authority figures who can appear to engage with that technical complexity while leading audiences to contrary conclusions. The authority is most needed, and most effective, exactly where genuine expertise is most genuinely required to evaluate competing claims.

The Anatomy of False Expertise: How It Is Manufactured

False expertise is not a single thing. It exists on a spectrum, and understanding that spectrum is essential to detecting it.

At one end sits genuine authority: credentials earned through verifiable institutional processes, in the relevant domain, without undisclosed conflicts of interest. A cardiologist who publishes peer-reviewed research on cardiovascular disease and recommends exercise and dietary intervention is exercising genuine authority. A climate scientist who has spent twenty years studying atmospheric chemistry and testifies before Congress about greenhouse gas concentrations is exercising genuine authority.

Moving along the spectrum, we encounter compromised authority: genuine credentials in the relevant domain, but with undisclosed or underweighted conflicts of interest that systematically bias the expert's public claims. A physician who publishes papers questioning statin safety while receiving consulting fees from supplement companies has genuine credentials, but those credentials are being deployed in the service of undisclosed financial interests. The expertise is real; the neutrality is not.

Further along still is borrowed authority: real credentials in one domain, applied to claims in a different domain where those credentials do not confer expertise. The Nobel laureate in chemistry who opines on evolutionary biology has genuine expertise — just not in the domain in question. The celebrity with a medical degree who promotes an investment strategy has genuine credentials — but not for financial advice. Borrowed authority exploits the heuristic by providing the credential signal while stripping away its domain-specific meaning.

At the far end sits manufactured authority: fabricated or fraudulently misrepresented credentials, institutions that exist only on paper, research that was ghost-written by industry scientists and published under independent academic names, and institutional affiliations that have been fabricated or inflated beyond what the underlying relationship justifies.

The specific tactics of authority manufacture are numerous. Credential inflation takes real but modest qualifications — a certificate course, a brief professional membership — and presents them with titles that imply something more substantial. Institutional fabrication involves creating organizations with impressive names ("The Institute for Science and Medicine," "The Global Health Research Consortium") that exist primarily to provide authoritative-sounding affiliations for industry-funded spokespeople. Ghost-written research is the practice, documented extensively in the tobacco and pharmaceutical industries, of having industry scientists produce papers that are then published under the names of academic researchers who receive payments for lending their names and institutional affiliations. Funding laundering routes industry money through intermediate foundations and think tanks before it reaches the researchers, creating distance between the funder and the funded conclusion.

The science studies scholar Naomi Oreskes and her co-author Erik Conway developed what they called the FLICC taxonomy — an acronym for the five most common techniques of science denial that exploit false expertise. The five are: False balance (presenting a tiny minority scientific position as equivalent to an overwhelming consensus), Logical fallacies (using formally invalid arguments to challenge scientific findings), Impossible expectations (demanding standards of certainty that science cannot and was never designed to provide), Cherry-picking (selecting individual studies or data points that support the preferred conclusion while ignoring the body of evidence), and Conspiracy theories (explaining away the scientific consensus by alleging coordinated fraud or bias among mainstream researchers). Each of these techniques has been deployed at industrial scale in specific historical cases — cases that illuminate the manufactured doubt strategy from its origins.

A note on the spectrum and its movement. False expertise rarely presents itself at the manufactured end of the spectrum. Propaganda is most effective when the authority manipulation is least visible. The most effective manufactured doubt campaigns have operated through genuinely credentialed scientists who genuinely had some scientific objections to specific aspects of the consensus — scientists whose position could be represented as legitimate scientific dissent rather than manufactured controversy. The funding relationship was what moved them along the spectrum from genuine to compromised authority; the strategic selection and amplification of their specific objections was what made them useful to the industry. This means that the detection challenge is not primarily to identify outright frauds — though those exist — but to identify the subtler pattern of genuine credentials combined with undisclosed interests and domain-inappropriate deployment. The six-step verification checklist at the end of this chapter addresses precisely this challenge.

Historical Timeline: The Manufactured Doubt Strategy, 1950–2010

Understanding the manufactured doubt strategy as it evolved across half a century helps reveal its remarkable consistency and its institutional durability.

1950: Doll and Hill publish their landmark case-control study establishing the statistical link between cigarette smoking and lung cancer. Wynder and Graham publish a concurrent study in the United States. The scientific picture begins to converge.

1952–1953: Ernst Wynder's experimental evidence that cigarette smoke condensate causes cancer in mice appears. Reader's Digest publishes "Cancer by the Carton," bringing the scientific findings to a mass audience. Public concern about smoking and health rises significantly.

1954: The major tobacco companies coordinate to publish the "Frank Statement to Cigarette Smokers," establishing the principle that the science is "unsettled" and pledging independent research. The Tobacco Industry Research Committee (TIRC) is formed, providing the institutional infrastructure for manufactured scientific authority.

1964: The U.S. Surgeon General's Advisory Committee report: "Cigarette smoking is a cause of lung cancer." The scientific consensus is now formally endorsed by the federal government's chief medical officer. The industry's manufactured doubt campaign intensifies in response.

1965: The Federal Cigarette Labeling and Advertising Act requires warning labels — but the initial warning language is weaker than the public health community sought, a product partly of industry lobbying using manufactured scientific uncertainty.

1969: The Brown & Williamson "Doubt Is Our Product" memo is written, articulating the manufactured doubt strategy in explicit terms that will not become public for decades.

1989: The Global Climate Coalition is established, extending the tobacco playbook to the emerging challenge of climate science.

1990s: Naomi Oreskes begins the archival research that will establish the connection between tobacco scientists and climate scientists.

1998: Andrew Wakefield's fraudulent Lancet paper launches the vaccine-autism manufactured doubt campaign. The thimerosal hypothesis launches a parallel track.

2006: The U.S. District Court for the District of Columbia rules in United States v. Philip Morris that the tobacco companies had engaged in a decades-long conspiracy to deceive the public about the health effects of cigarettes, and orders specific remedies.

2010: Oreskes and Conway publish Merchants of Doubt, completing the archival case that the same network of scientists had moved across multiple manufactured doubt campaigns.

Big Tobacco: The Original Manufactured Doubt Machine

To understand false expertise as a propaganda tool, there is no more instructive case than the tobacco industry's response to the emerging scientific consensus on smoking and cancer in the 1950s and 1960s. What the industry developed during those two decades was not merely a defensive public relations strategy. It was a template — a systematic, documented methodology for using manufactured scientific doubt to delay regulatory action — that was subsequently adopted by industries facing inconvenient scientific findings for the next half-century.

The scientific picture in the early 1950s was becoming uncomfortable for the tobacco industry. Richard Doll and Austin Bradford Hill published their landmark case-control study in 1950, establishing a statistical association between cigarette smoking and lung cancer of a magnitude that was difficult to explain by any alternative hypothesis. Wynder and Graham published a similar study in the United States in the same year. By 1952, Ernst Wynder, Evarts Graham, and Adele Croninger had produced experimental evidence that cigarette smoke condensate caused cancer in mice. The epidemiological evidence was accumulating rapidly; the biological plausibility of the link was being established. A 1954 American Cancer Society prospective study of 187,000 men confirmed and strengthened the association.

The industry faced a strategic problem. The science was not yet conclusive in the sense of being unambiguously proven beyond all alternative explanations — as science rarely is in its early stages. But it was credible, accumulating, and alarming enough that ordinary smokers and their physicians were beginning to pay attention. Something had to be done not to disprove the science — that was not achievable — but to forestall its social and regulatory consequences.

The instrument chosen was doubt.

On January 4, 1954, the major American tobacco companies published a full-page advertisement in 448 newspapers across the United States. It was titled "A Frank Statement to Cigarette Smokers." The document is worth reading carefully, because it established several patterns that would recur for decades.

The Frank Statement acknowledged that reports linking tobacco to cancer had "given wide publicity to a theory that cigarette smoking is in some way linked with lung cancer." It characterized this as an "hypothesis" and stated that "distinguished authorities" had pointed out that the evidence was "not regarded as conclusive." It then made a series of commitments: the industry would fund independent research into the question; it would make all research findings available to the public; it would "cooperate closely" with public health officials.

The Frank Statement had several functions simultaneously. It managed immediate public alarm by framing the scientific findings as a "theory" — invoking the word in its colloquial sense (a guess, a speculation) rather than its scientific sense (a well-evidenced explanatory framework). It repositioned the industry as a responsible actor taking the concern seriously rather than dismissing it. And it created the apparatus of an ostensibly independent scientific investigation — the Tobacco Industry Research Committee (TIRC), which became the Council for Tobacco Research — that would provide the institutional foundation for the manufactured doubt campaign.

The TIRC was nominally independent. It had a scientific advisory board composed of respected scientists. It funded genuine research. But it was funded entirely by the tobacco industry and operated with the tobacco industry's strategic interests as its orienting concern. Documents subsequently obtained through litigation showed that the TIRC's primary function was not to discover the truth about tobacco and health but to generate scientific activity and scientific-sounding claims that could be cited to support the position that the science was unsettled.

The manufactured doubt strategy became explicit in a 1969 internal memorandum produced by Brown & Williamson, one of the major tobacco companies. The memo, addressed to the company's president, set out the communications strategy in language of unusual candor. The key passage read:

"Doubt is our product since it is the best means of competing with the 'body of fact' that exists in the mind of the general public. It is also the means of establishing a controversy."

This is the clearest surviving statement of the manufactured doubt strategy as an explicit, deliberate methodology. The author did not claim that the evidence linking tobacco to cancer was false. The goal was not to disprove the evidence. The goal was to establish a controversy where, from a scientific standpoint, the evidence was rapidly converging on a conclusion. The instrument of that controversy was doubt — manufactured through recruited scientists, funded research, institutional infrastructure, and media amplification.

The industry's approach to recruiting scientists was sophisticated. It did not seek out frauds or incompetents. It sought out credentialed, published scientists who had, for whatever combination of reasons, a skeptical disposition toward the emerging consensus on tobacco and health. Some had genuine scientific objections to aspects of the methodology. Some had financial motivations. Some had temperamental inclinations toward contrarianism. The industry funded these scientists through grants, speaking fees, consulting contracts, and publication support — providing them with the resources to produce and disseminate their heterodox views.

The result was a minority scientific position that could be amplified far beyond its proportional representation in the scientific community. Even if the consensus among oncologists, epidemiologists, and public health researchers was running at 95 percent in favor of the tobacco-cancer link, a handful of credentialed, published skeptics — funded and supported by the industry — could be deployed to testify before Congress, to appear on television, and to be cited in press releases as evidence that "scientists disagree."

The "controversy" thus constructed was not a genuine scientific controversy. It was a social and institutional artifact, manufactured by strategic investment in a small number of credentialed dissenters. But it was effective. The industry successfully delayed major federal regulatory action on cigarette advertising and warning labels for years, and succeeded in creating sufficient public confusion to sustain tobacco consumption at levels that, by subsequent health analyses, resulted in hundreds of thousands of preventable deaths.

The tobacco playbook did not remain confined to tobacco. The same strategic approach — the same deployment of funded contrarian experts, the same institutional infrastructure of ostensibly independent research organizations, the same media strategy of promoting doubt rather than disproving the consensus — was subsequently used by the lead industry to dispute the evidence that leaded gasoline and lead paint caused cognitive damage in children; by the asbestos industry to dispute the evidence that asbestos caused mesothelioma; by the chemical industry to dispute evidence of pesticide toxicity; and, most consequentially in terms of global stakes, by the fossil fuel industry to dispute the scientific consensus on anthropogenic climate change.

The template was durable because the underlying psychology it exploited was durable. The expertise heuristic could be manipulated in either direction: genuine experts could be recruited to lend their credentials to industry positions, and the resulting "scientific controversy" could exploit audiences' appropriate uncertainty about science they were not equipped to evaluate independently.

It is worth pausing to consider what made the tobacco template so transferable. The template's core insight — that manufactured scientific controversy is more cost-effective than either genuine scientific rebuttal or straightforward public denial — is not industry-specific. Any industry facing costly regulatory consequences of inconvenient scientific findings faces the same basic calculus. Genuine scientific rebuttal requires actually being right, which the tobacco industry was not and knew it was not. Public denial is credibility-destroying. But manufacturing uncertainty — sponsoring a small number of credentialed dissenters, creating institutional structures that can claim independence, and deploying the media's "both sides" convention to amplify a minority position — is achievable regardless of the underlying scientific facts, relatively inexpensive compared to regulatory costs, and deniable if exposed. The template traveled because the strategic logic is sound, the costs are low, and the psychological mechanism it exploits — the expertise heuristic applied to a technically complex domain — is universal.

Climate Denial and Merchants of Doubt

In 2010, the science historians Naomi Oreskes and Erik Conway published Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming. It was not a theoretical argument about how the manufactured doubt strategy might work. It was an archival history documenting, through internal documents and public records, that the same strategy had been deliberately deployed across multiple industries — and, crucially, that the same individual scientists had been involved in multiple iterations of it.

The central finding of Oreskes and Conway's research was that a small network of physicists and scientists — primarily drawn from Cold War defense research — had moved systematically from one manufactured doubt campaign to another. Frederick Seitz, a former president of the National Academy of Sciences and a man whose scientific credentials were as genuine as any in twentieth-century American physics, worked first for the tobacco industry — as scientific director of a major R.J. Reynolds research program — and then became a prominent spokesperson for climate science skepticism. Fred Singer, another physicist with genuine credentials in atmospheric science, moved from defending secondhand smoke to challenging the ozone layer science to challenging climate change. Robert Jastrow, William Nierenberg — the same names appeared across decades of manufactured controversy.

These were not scientists without qualifications. They were scientists with strong qualifications who had made a political choice — rooted, Oreskes and Conway argued, in a visceral Cold War-era suspicion of government regulation as a path toward socialism — to deploy their credentials in the service of slowing or preventing regulatory intervention in private industry. Their genuine authority in physics gave them access to platforms and credibility that allowed them to function as amplifiers of manufactured doubt far beyond what their expertise in the specific contested fields (oncology, atmospheric chemistry, climate science) would have justified.

The climate denial campaign had institutional infrastructure to match. The Global Climate Coalition, a trade association representing fossil fuel companies, operated from 1989 to 2002 as a coordinating body for industry opposition to climate science and climate policy. Internal documents subsequently obtained through litigation showed that the Coalition's own scientists had advised the organization's leadership as early as 1995 that the scientific basis of the human-enhanced greenhouse effect was well-established. The Coalition publicly maintained the opposite — that the science was contested and uncertain — while privately acknowledging the consensus.

One of the most vivid examples of manufactured scientific consensus in the climate context was the "Oregon Petition," formally titled the Global Warming Petition Project, circulated in 1998. The petition claimed to have gathered signatures from 31,000 scientists asserting that there was no convincing evidence that human greenhouse gas emissions were causing catastrophic heating of the atmosphere. The petition was sent with a cover letter formatted to resemble the Proceedings of the National Academy of Sciences and accompanied by a paper formatted in the journal's style — but neither the letter nor the paper had any connection to the NAS. The NAS disavowed the petition explicitly.

Subsequent analysis of the signatories found that fewer than 1 percent held expertise in climate science. "Scientists" included, in some reports, names that appeared to be fabricated or duplicated. The petition illustrated the FLICC false balance technique in its most concentrated form: by manufacturing the appearance of a large scientific coalition — 31,000 signatures sounds impressive to a general audience — it created the impression of a genuine scientific controversy where the actual climate science community had reached overwhelming consensus.

The mechanism the manufactured doubt campaign exploited was the same one the tobacco industry had identified in 1969: you do not need to disprove the science. You need only to establish sufficient uncertainty in the public and political mind that action is delayed. For industries facing regulatory costs measured in the billions of dollars, even a few years of delay represented enormous financial value. The investment in manufactured doubt was trivially small by comparison.

The journalism dimension of the climate story deserves specific attention because it illustrates how the manufactured doubt strategy interacted with media norms to amplify its effect. Throughout the 1990s and into the 2000s, major news organizations operated under a "balance" norm that led them to present "both sides" of the climate science debate — giving equal representational weight to the overwhelming scientific consensus and to the tiny minority of funded skeptics. This was not journalistic neutrality; it was a systematic distortion that misrepresented the actual distribution of scientific opinion. A report that quoted three climate scientists affirming human-caused warming and one contrarian skeptic gave audiences a fundamentally false picture of the state of scientific knowledge. The FLICC false balance technique depended on journalism's "both sides" convention to translate a manufactured minority position into an apparently genuine scientific debate.

The Anti-Vaccine Manufactured Doubt Campaign

The anti-vaccine movement's relationship with false expertise is particularly instructive because it illustrates what happens when manufactured doubt continues to propagate after the original manufactured authority has been thoroughly discredited.

In February 1998, the British medical journal The Lancet published a paper by Andrew Wakefield and twelve co-authors claiming to document a link between the MMR (measles, mumps, rubella) vaccine and a developmental condition the paper called "autistic enterocolitis." The paper had twelve patients — twelve — and its methodology was severely limited even by the authors' own description. But Wakefield was a gastroenterologist at the Royal Free Hospital in London, a credentialed specialist, and the paper carried the imprimatur of one of the world's most respected medical journals. The claim generated enormous media attention.

What was not disclosed in the paper was that Wakefield had been paid approximately £400,000 (the equivalent of considerably more in today's values) by a lawyer who was preparing a lawsuit against vaccine manufacturers. The lawyer, Richard Barr, had retained Wakefield specifically to produce evidence for litigation. This represented a massive conflict of interest — the kind of compromised authority discussed earlier in this chapter — that, had it been disclosed, would have immediately altered the reception of the paper.

The subsequent scientific examination of Wakefield's claims was comprehensive and unambiguous. Thirteen large-scale epidemiological studies in multiple countries, collectively involving millions of children, found no association between the MMR vaccine and autism. In 2004, investigative journalist Brian Deer published evidence that Wakefield had manipulated patient data. In 2010, The Lancet fully retracted the paper. The General Medical Council found Wakefield guilty of serious professional misconduct; he was struck off the medical register and lost his license to practice in the United Kingdom.

The authority that had launched the anti-vaccine movement — Wakefield's genuine medical credentials, the Lancet's institutional imprimatur — had been thoroughly dismantled. But the manufactured doubt had not been. In the decade between the 1998 paper and its 2010 retraction, the claim had propagated through parent communities, celebrity amplification (Jenny McCarthy became the highest-profile public advocate in the United States), and, crucially, the early internet. By the time the retraction came, the claim had been encountered millions of times, in multiple languages, across multiple media. The fluency that repetition builds — a mechanism explored in depth in Chapter 11 — meant that for many people, the anti-vaccine claim felt familiar and therefore credible in a way that the much drier scientific rebuttals did not.

The subsequent social media era created a new infrastructure for anti-vaccine authority claims. Influencers with medical degrees — or with no medical training at all — could build audiences measured in the hundreds of thousands or millions, and within those audiences, the repeated claims of the original manufactured doubt could be refreshed, reformulated, and amplified without any reference to their discredited origins. The authority signal — the medical degree, the professional-looking content, the apparent sincerity — traveled independently of the evidence.

This phenomenon illustrates a critical asymmetry in the dynamics of false expertise. Genuine authority requires sustained institutional investment: years of training, peer review, replication, and institutional validation. Borrowed or manufactured authority requires only the appearance of those things. And once a manufactured doubt claim has been sufficiently amplified, its authority — such as it is — becomes partially independent of any individual source. The claim circulates; the credentials attached to it fade into the background; what remains is a familiar-feeling assertion that carries, through its very familiarity, an aura of credibility.

Digital Authority and Influencer Propaganda

The digital media environment has created new authority architectures that both reproduce and transform the traditional mechanisms of false expertise.

Traditional media authority was institutional: newspapers, television networks, and academic publishers served as credibility-conferring gatekeepers. A claim published in The New York Times carried weight partly because readers trusted the Times's editorial and fact-checking processes. A study published in a peer-reviewed journal carried weight partly because readers understood that it had survived expert scrutiny before publication. These gatekeeping functions were imperfect — they failed in documented cases, including the Wakefield paper — but they represented a mechanism for some degree of authority calibration.

Digital media has substantially weakened these gatekeeping functions while creating new authority signals. In the influencer economy, authority is signaled through follower count, engagement rate, visual production quality, professional title in the bio, and the presence of a blue verification checkmark. None of these signals reliably track the quality of the underlying expertise. A dermatologist with 2 million followers has genuine authority in dermatology; she has derivative authority, at best, in nutritional biochemistry; she has no special authority in immunology. But her 2 million followers do not recalibrate their trust based on domain relevance. The authority signal — the follower count, the verified badge, the MD in the bio — travels with her across domain boundaries.

The "Dr." prefix and its exploitation in digital health content deserves specific attention. The title "Doctor" is understood by most people to mean "physician" — a licensed medical practitioner who has completed medical school and postgraduate training. But "Doctor" also applies to holders of doctoral degrees in any discipline: PhDs in education, psychology, history, and — crucially — nutrition, naturopathy, and chiropractic medicine. A "Dr." promoting an anti-vaccine claim on social media may be a licensed medical physician making a claim that contradicts her own training, or she may hold a doctorate in a field that does not confer the expertise audiences assume.

Influencer marketing represents a specific structural form of manufactured authority in digital media. When a health influencer with genuine medical credentials promotes a supplement product, her followers encounter what appears to be an expert recommendation. In practice, the recommendation has been purchased — the influencer has been paid to make it. The Federal Trade Commission requires disclosure of material connections between influencers and the brands they promote, but enforcement has been inconsistent, disclosures are often formatted and placed in ways that minimize their salience, and the distinction between a paid promotion and a genuine recommendation is lost on many audiences.

The algorithm amplification dimension compounds these effects. Platforms optimize for engagement, and health misinformation — which tends to be emotionally charged and identity-affirming for specific communities — generates higher engagement rates than accurate health information, which is often nuanced and hedged in ways that are less emotionally satisfying. The result is that false expertise claims are amplified by platform recommendation systems even without any coordinated campaign behind them.

The Ingrid's opening parallel — the 1946 Camel advertisement and the 2020s supplement influencer — captures something important about how these dynamics have and have not changed across the decades. The structural similarity is genuine: in both cases, medical credentials earned in one context (clinical medicine, medical school training) are being deployed to transfer authority to a claim in a different context (tobacco product safety, supplement efficacy). In both cases, the audience has no obvious mechanism for verifying whether the authority transfer is warranted. In both cases, the institutional framework has failed to require transparency about the financial relationship between the authority figure and the claim.

But the differences are also significant. The 1946 physician advertisement was produced by a known commercial entity — R.J. Reynolds Tobacco — and its commercial origin was, if not prominent, at least identifiable. The contemporary health influencer post exists within an information ecosystem that systematically obscures commercial relationships: the #ad tag is often buried, the influencer's agency relationship is not disclosed, the supplement company's funding of the influencer's entire content strategy is not visible. The manufactured authority is more seamlessly embedded in what appears to be authentic personal testimony and expert recommendation.

There is also the question of scale. The 1946 newspaper advertisement reached a large but finite audience — those who read the specific publications in which it ran on the specific days it ran. The contemporary influencer post reaches its audience in perpetuity (the post remains on the platform indefinitely), is algorithmically served to users who have not specifically chosen to follow the influencer, and can be shared across platforms and contexts in ways that multiply its reach unpredictably. The mechanism is the same; the transmission infrastructure is orders of magnitude more powerful.

Ingrid's research found that the European regulatory approach has made some progress on the disclosure dimension — requiring clearer labeling of paid health content, establishing verification requirements for medical credentials used in commercial health claims — while making less progress on the algorithmic amplification dimension, where the challenge of jurisdiction and platform power has proved harder to address. The manufactured authority problem, in other words, is partially a disclosure problem that regulation can address, and partially a structural problem of the attention economy that disclosure requirements alone cannot fully solve.

Counter-Expertise and Lateral Reading

Understanding how false expertise is manufactured is the first step. The second is developing practical tools for evaluating authority claims in real time — without requiring the kind of domain expertise that, by definition, most of us lack in most domains.

The most powerful general-purpose tool for evaluating authority claims is a technique called lateral reading, developed and studied by media literacy researchers at the Stanford History Education Group. Lateral reading means leaving the page or source you are evaluating and opening new tabs to read about the source — checking what others say about it — rather than reading within it to evaluate its internal claims on their merits.

The internal evaluation approach — reading a claim carefully, assessing the logic and evidence as presented — is the approach most educated people instinctively use. It is also the approach that false expertise is specifically designed to defeat. A well-manufactured expert witness, a sophisticated ghost-written research paper, or a credible-looking institutional website may be internally coherent, citation-rich, and professionally produced. Evaluating the content as presented gives the evaluator little purchase.

Lateral reading circumvents this problem by asking a different question: not "is this claim internally convincing?" but "what do independent observers with knowledge of this source say about it?" A quick lateral search on an unfamiliar think tank will typically reveal, within seconds, whether it is editorially independent or industry-funded, whether its principals have documented conflicts of interest, and whether its claims are recognized or disputed by researchers in the relevant field.

The Stanford SIFT method — Stop, Investigate the source, Find better coverage, Trace claims — provides a structured framework for applying lateral reading to authority claims specifically:

Stop means interrupting the automatic trust-transfer that occurs when you encounter authority signals. Before extending trust, pause and apply the remaining steps.

Investigate the source means opening new tabs to check what independent sources say about the authority being cited. Who funds this organization? What is this researcher's publication record? Has this credential been verified? What do mainstream researchers in this field say about this source's work?

Find better coverage means checking whether the claim being made is corroborated by sources whose independence and expertise are established. If a claim is true and significant, it should appear in multiple independent high-quality sources. If it appears primarily on platforms associated with a specific ideological or commercial interest, that is diagnostic.

Trace claims means following citations back to their original sources. Many manufactured doubt claims are built on a citation chain that, when traced, leads either to a single poorly conducted study, to a genuinely contested finding that has been misrepresented, or to a circular citation structure in which industry-funded sources cite each other.

The combination of lateral reading and claim tracing is particularly powerful for authority claims because it focuses attention on the source's track record and funding rather than on the internal coherence of the specific claim being evaluated. A source that has a documented history of producing industry-funded claims that contradict scientific consensus is providing weak evidence regardless of how internally persuasive its current presentation is.

Following the funding is a specifically powerful application of lateral reading to authority claims. Because the manufactured doubt strategy depends on creating apparent independence between the funder and the funded conclusion, the funding relationship is typically obscured. Databases such as those maintained by the Union of Concerned Scientists, the Center for Science in the Public Interest, and — for political organizations — OpenSecrets and InfluenceMap allow researchers to trace funding from industry sources through intermediate foundations and think tanks to the individual researchers and organizations that produce the doubt.

These tools are not perfect. Funding relationships are often structured to minimize discoverability; researchers who receive industry funding are sometimes genuinely independent in their conclusions; and not every organization funded by industry is producing distorted science. The goal is not to dismiss any source with industry connections but to calibrate trust appropriately — treating funding relationships as relevant information about potential bias rather than as automatic disqualifications.

Research Breakdown 1: Merchants of Doubt and the Archival Method

Naomi Oreskes is a professor of the history of science at Harvard University. Erik Conway is a historian of science and technology at NASA's Jet Propulsion Laboratory. Their 2010 book Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming is one of the most consequential works of investigative history produced in the early twenty-first century. Understanding how they established their findings is itself a lesson in evaluating evidence.

The book's central argument — that the same small network of scientists moved from tobacco defense to climate denial through a series of other manufactured doubt campaigns — was not established through interviews with the scientists in question (who denied it) or through analysis of their public statements (which were crafted to project independence). It was established through archival research: the systematic examination of internal documents from the tobacco industry, released through litigation discovery and subsequently made public in the Legacy Tobacco Documents Library at the University of California, San Francisco.

The tobacco litigation of the 1990s had an extraordinary epistemic consequence. Court proceedings forced the tobacco companies to disclose internal documents — memos, strategy papers, correspondence, research files — that had been created in the expectation of confidentiality. These documents revealed, in the words of the participants themselves, the strategy that had been publicly denied: the deliberate manufacture of scientific doubt, the recruitment of scientists for their credentials rather than their expertise in the contested domains, the explicit understanding that the goal was delay rather than disproof.

Oreskes and Conway cross-referenced these tobacco documents with the public records of scientists who subsequently appeared as climate skeptics, with the funding records of think tanks and advocacy organizations, and with the public statements of the scientists involved. The pattern that emerged was documented not through inference or extrapolation but through the participants' own internal communications.

This methodological point has implications for how students of propaganda should evaluate historical claims. The manufactured doubt strategy is specifically designed to resist evaluation through surface-level reading — through examining the public claims of industry spokespeople and funded scientists. It is vulnerable to archival and forensic investigation precisely because it depends on concealment. When the concealment is breached — through litigation, whistleblowing, or investigative journalism — the internal documents that emerge tend to be unusually candid about goals and strategies that the public communications carefully obscure.

The Legacy Tobacco Documents Library, which is publicly accessible online, contains more than fourteen million pages of internal tobacco industry documents. It is one of the most valuable primary source archives for anyone seeking to understand the manufactured doubt strategy in its original context.

Research Breakdown 2: Milgram's Obedience Studies

Stanley Milgram began his obedience experiments in July 1961, shortly after the trial of Adolf Eichmann in Jerusalem — a trial that had raised urgent questions about the psychological mechanisms that allow ordinary people to participate in atrocities. Milgram's question was whether the Holocaust required an unusually cruel or psychologically abnormal population, or whether ordinary American adults, under the right conditions, would also comply with authority directives to harm others.

The basic experimental design has been described earlier in this chapter, but the specific procedural details of what Milgram called the "voice feedback" condition — the one that produced the 65 percent compliance rate — are instructive. The learner's prerecorded protests escalated systematically as the voltage increased: complaints at 75 volts, demands to be released from the experiment at 150 volts, screaming at 270 volts, and then — crucially — silence from 315 volts onward. The silence was more disturbing to many participants than the screaming, because it left them uncertain whether the learner was unconscious or dead.

When participants expressed reluctance or hesitation, the experimenter — in a gray lab coat, with a calm, professional manner — delivered one of four standardized prompts in sequence: "Please continue," "The experiment requires that you continue," "It is absolutely essential that you continue," and "You have no other choice, you must go on." These prompts were not threatening. They did not involve coercion, financial incentives, or promises of benefit. They were simply the measured insistence of an authority figure in an institutional setting.

The institutional setting was important. Milgram subsequently varied the experimental conditions systematically. When the experiment was conducted in a building in Bridgeport, Connecticut, presented as belonging to a private commercial research firm rather than Yale University, the compliance rate fell to 47.5 percent — still extremely high, but significantly lower than the Yale condition. The prestige of the institutional setting — Yale University, a scientific laboratory — contributed substantially to the perceived legitimacy of the authority.

Milgram also found that the physical proximity of the learner affected compliance: when the learner was in the same room as the teacher, and the teacher had to physically force the learner's hand onto the shock plate, compliance fell to 30 percent. Distance — physical, emotional, and institutional — from the consequences of compliance facilitated it.

Later researchers raised legitimate ethical objections to Milgram's procedures. Participants were deceived, did not give fully informed consent, and in some cases experienced acute psychological distress during the experiment. Milgram's own debriefing procedures have been debated. Partial replications under more ethically constrained conditions — including a 2009 study by Jerry Burger at Santa Clara University that stopped at 150 volts (the point at which the learner first explicitly demanded to be released) — found compliance rates in the same general range as Milgram's original findings, suggesting the basic effect is robust.

The implications for propaganda analysis are significant. Milgram demonstrated that authority compliance is not a marginal phenomenon confined to psychologically unusual individuals. It is a central tendency of ordinary human behavior, modulated by contextual factors — institutional setting, physical distance, explicit legitimacy signals — that propaganda operations can deliberately configure.

Primary Source Analysis: The Brown & Williamson "Doubt Is Our Product" Memo (1969)

Source: Internal memorandum, Brown & Williamson Tobacco Corporation, 1969. Author identified only by position. Addressed to the company's president. Now held in the Legacy Tobacco Documents Library, University of California, San Francisco (document identification number: 680561778-1786).

Context: By 1969, the scientific evidence linking cigarette smoking to lung cancer and cardiovascular disease was overwhelming. The U.S. Surgeon General had issued his landmark report in 1964 declaring smoking a cause of lung cancer. Congressional pressure for warning labels and advertising restrictions was intensifying. This memo appears to have been a strategy document for managing the public information environment.

The Key Passage: "Doubt is our product since it is the best means of competing with the 'body of fact' that exists in the mind of the general public. It is also the means of establishing a controversy."

What the passage reveals about strategy: The author explicitly acknowledges that there is a "body of fact" in the public mind — the consensus scientific understanding of smoking's health consequences. The strategy is not to disprove that body of fact (which the author implicitly concedes cannot be done). The strategy is to compete with it — to introduce sufficient uncertainty that the public's confidence in the settled science is eroded. The word "compete" is striking: it frames the scientific consensus as an adversary in a marketplace of claims, not as a factual matter to be engaged on its merits.

What the passage reveals about means: The instrument for establishing controversy is doubt — manufactured doubt, introduced through the institutional apparatus of the Tobacco Industry Research Committee, the funded contrarian scientists, and the media strategy of amplifying the minority scientific position.

Emotional register: The document is businesslike, strategic, and entirely unapologetic. There is no indication that the author experienced any tension between the strategy being outlined and the health consequences of the product being defended. The frame is commercial competitive strategy, not health communication. This is important: the manufactured doubt strategy was conceived within a business logic, not a scientific one.

Implicit audience: The memo's audience is corporate leadership — people who already understand the gap between the company's public positions and the internal understanding of the scientific evidence. This is a strategy document for managing the gap, not a document designed to influence public opinion directly.

Strategic omission: The memo does not discuss the health effects of the product at all. The tens of thousands of Americans dying each year from tobacco-related illness are entirely absent from the document. This omission is diagnostic: the manufactured doubt strategy requires that the human costs of the delay it seeks remain invisible to those who design and implement it.

Historical significance: This memo became, after its disclosure through litigation, the single most widely cited piece of evidence for the deliberate nature of the manufactured doubt strategy. It gave a name — "doubt is our product" — to a strategy that the industry had carefully avoided naming in its public communications. Its disclosure transformed the historical understanding of the tobacco controversy from a case of industry-funded research into a case of deliberate deception.

Debate Framework: Exploiting Genuine Uncertainty vs. Manufacturing the Impression of Uncertainty

The manufactured doubt strategy raises a genuine philosophical question about the nature of scientific uncertainty and its exploitation. The question can be framed as follows:

Does the manufactured doubt strategy succeed because it exploits legitimate scientific uncertainty, or does it succeed primarily by manufacturing the impression of uncertainty where none substantially exists?

Position A: The doubt strategy exploits genuine uncertainty. Science advances through the accumulation of evidence, not the sudden arrival of absolute proof. At any given moment in the development of a scientific consensus, there is genuine residual uncertainty — methodological limitations, alternative hypotheses that have not been definitively ruled out, questions about mechanisms and dose-response relationships that remain open. The tobacco industry did not invent the uncertainty that existed in the early 1950s about the precise causal mechanisms through which smoking causes cancer. It found genuine scientists with genuine objections to specific aspects of the evidence, and funded their continued engagement with those objections. The strategy worked, on this view, because it found real fault lines in the scientific enterprise and widened them.

Position B: The doubt strategy manufactures the impression of uncertainty through social and institutional mechanisms. The genuine scientific uncertainty in any of the tobacco-climate-vaccine cases was modest and rapidly diminishing; the public impression of uncertainty was vastly larger than the scientific reality warranted. This gap cannot be explained by the quality of the contrarian scientific arguments — which were, in the assessment of the mainstream scientific community, unconvincing. It can only be explained by the social and institutional amplification of a minority position: the institutional infrastructure (funded think tanks, named research committees, professional-sounding spokespeople), the media coverage (which the "both sides" norm required to treat the minority position as equivalent to the majority), and the commercial investment in distribution and repetition. The doubt strategy succeeded not because it produced compelling arguments but because it produced compelling appearances of controversy through media and institutional manipulation.

Toward a resolution: The two positions are not mutually exclusive. The manufactured doubt strategy is most effective when it can find genuine but limited scientific uncertainty and amplify it beyond its proportional significance — using Position A's real fault lines to support Position B's manufactured appearance. The tobacco case suggests that even quite modest genuine uncertainty can be amplified into a publicly convincing controversy through sufficient institutional investment. This means that the manufactured doubt strategy does not require that contrarian scientists be wrong about everything — only that their genuine objections to specific aspects of the evidence can be presented, to non-specialist audiences, as casting doubt on the entire body of evidence.

Argument Map: Does Funded Research Produce Systematically Biased Results?

Central Claim: Research funded by private industry produces systematically biased findings favorable to the funder's commercial interests.

Supporting Evidence: - A 2003 meta-analysis by Bekelman, Li, and Gross in JAMA found that industry-funded studies were significantly more likely to reach pro-industry conclusions than independently funded studies of the same interventions. - The tobacco documents reveal explicit strategies for suppressing unfavorable findings and amplifying favorable ones. - The pharmaceutical industry's documented pattern of selective publication — registering trials, running them, and publishing only the ones with favorable results — has been extensively analyzed (Turner et al., 2008, in the New England Journal of Medicine, on antidepressant trial publication bias). - The climate denial case provides documented instances of industry funding flowing to research that produced pro-industry conclusions.

Objection 1: Research funding does not determine findings; researchers maintain independence. Many industry-funded researchers produce findings unfavorable to their funders; many independently funded researchers produce findings that happen to align with industry positions.

Response to Objection 1: The bias is systematic, not universal. The claim is not that industry funding always produces distorted findings, but that the distribution of findings from industry-funded research is systematically skewed toward funder interests relative to independently funded research. A systematic bias can exist even when many individual instances deviate from it.

Objection 2: Academic and government-funded research also reflects the biases and interests of its funders. Government agencies have policy agendas; academic researchers have career incentives to produce novel positive findings.

Response to Objection 2: The biases of academic and government research are real and worth acknowledging. But the direction of these biases does not reliably align with the interests of any specific commercial enterprise, whereas industry funding by definition runs toward funder interest. Multiple funding sources with different and sometimes competing interests provide a form of diversity that partially corrects for individual source bias; single-industry funding provides no such correction.

Conclusion: The weight of systematic evidence supports the view that industry funding introduces a significant bias toward funder-favorable conclusions, while recognizing that the mechanism is probabilistic rather than deterministic and that independent funding does not guarantee unbiased findings.

Action Checklist: Authority Verification in Six Steps

When encountering a claim backed by an authority — an expert, an organization, or an institutional affiliation — the following six-step process allows systematic evaluation without requiring domain expertise.

Step 1: Identify the specific authority claim. What credentials, titles, or institutional affiliations are being cited? Note the exact formulation. "Senior researcher at the Institute for Science and Medicine" is different from "former professor at a major research university."

Step 2: Verify the institution. Open a new tab and search the institution's name. Look for its Wikipedia entry, its IRS Form 990 (for nonprofit organizations in the U.S., these are publicly available and list leadership and funding), and any news coverage that mentions its funding sources. Ask: does this institution have an established track record of publishing in peer-reviewed venues? Is it primarily a communications organization that produces policy reports, or does it conduct original research?

Step 3: Verify the credential. Can the individual's credential be independently confirmed? University faculty pages, professional licensing boards, and Google Scholar profiles provide independent verification. Is the credential in the relevant domain, or is authority being borrowed across domains?

Step 4: Follow the funding. Search the expert's name along with "funding," "conflict of interest," or "disclosed financial relationships." Check databases such as OpenPayments (for pharmaceutical industry payments to physicians in the U.S.) or InfluenceMap (for corporate funding of climate-related advocacy). Note that absence of disclosed conflicts is not the same as absence of conflicts.

Step 5: Check the consensus context. What does the mainstream scientific or expert community in this domain say about the claim? This does not require finding individual dissenting experts — it requires establishing the approximate distribution of professional opinion. A claim supported by a majority of relevant professional bodies is in a fundamentally different evidential position than a claim supported only by a funded minority.

Step 6: Assess the track record. Has this expert or organization made verifiably false or systematically misleading claims in the past? A track record of produced-for-industry testimony across multiple topics is diagnostic information even if the current claim cannot be immediately evaluated on its merits.

Inoculation Campaign: Technique Identification Matrix — Row 4

The Inoculation Campaign is a cumulative project developed throughout this course. Each chapter contributes one row to the Technique Identification Matrix, which your campaign will use to help your target community recognize specific propaganda techniques. This chapter contributes Row 4: Appeals to Authority and False Expertise.

Row 4: Appeals to Authority and False Expertise

Complete Row 4 by identifying at least one specific authority claim — citing a named expert or organization — that circulates in your target community's information environment. Apply the six-step verification checklist and document your findings. What did lateral reading reveal that internal reading of the source would not have?

The deeper implication of the Inoculation Campaign row above is that the target community exercise is itself a form of inoculation. By identifying and verifying a specific authority claim from the community's media environment, students are not merely completing an academic exercise — they are building the specific cognitive habits that make automatic trust transfer visible and interruptible. Verification, practiced enough times, becomes habitual. The six-step checklist, consulted often enough, ceases to feel like a laborious procedure and begins to feel like a natural part of the process of encountering any authority-backed claim. At that point, the manufactured doubt strategy's most important target — the unexamined deference to credentials — has been specifically addressed.

Ingrid's research, with its focus on regulatory frameworks, adds an important institutional dimension to this individual-level resistance. Individual media literacy is valuable; structural reform that makes authority claims more transparent and conflicted interests more visible is more powerful, because it changes the information environment rather than placing the full burden of skepticism on individual recipients. The most resilient societies will deploy both: education that builds individual verification capacity, and regulation that makes the environment more honest about the relationships between authority and interest. Neither alone is sufficient; both together represent the most defensible response to the manufactured doubt machinery whose origins this chapter has examined.

Chapter 10 is part of Part Two: Techniques. The next chapter examines repetition and the illusory truth effect — a mechanism that works in concert with false expertise to establish the impression of broad consensus for manufactured claims.